MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
Model Number PED2-400-12 |
Device Problems
No Apparent Adverse Event (3189); Migration (4003)
|
Patient Problems
Therapeutic Response, Decreased (2271); No Known Impact Or Consequence To Patient (2692)
|
Event Date 09/11/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
The pipeline device will not be returned for evaluation as it was implanted in the patient.The device was not returned; the reported event could not be confirmed.The cause of the event could not be conclusively determined from the reported information.The device involved in this event is not approved in the us; the device's brand name and model number are provided below.This report is being filed against a similar device, which is provided.Brand name: pipeline flex with shield technology model number: ped2-400-12.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information through a clinical study that complete neck coverage was not achieved one year after pipeline flex with shield treatment of an aneurysm.The device had been placed to treat two aneurysms.Post procedural imaging showed complete stasis with class 3 aneurysm occlusion.The patient underwent pipeline embolization treatment for a previously ruptured saccular sidewall aneurysm measuring 10mm x 6mm x 10mm x 2mm (dia, hgt, wth, nck) located in the right c7 communicating segment.The distal and proximal diameter of the parent artery was 3.8mm x 4.1mm.The patient was discharged home three days post procedure for self care.
|
|
Manufacturer Narrative
|
Updated sections: b5 - additional information h6 - changed device and patient codes based on the additional information, there is no device malfunction or patient injury.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information additional information: "neck coverage was achieved at 1 year follow up visit.
|
|
Search Alerts/Recalls
|
|
|